Another study based on liver failure in mice reported that myeloperoxidase (MPO) and MDA levels were reduced, and SOD and CAT activities were improved with myricetin at doses of 50 and 100 mg/kg pretreatment. The gene discussed is MPO; the disease is liver failure.